Ozempic and Wegovy are two brand names for semaglutide injection: Ozempic is approved for type 2 diabetes and Wegovy for chronic weight management, heart-risk reduction and MASH.
Same molecule, two labels
Semaglutide is the drug. Ozempic is the brand Novo Nordisk sells for type 2 diabetes: to control blood sugar, to lower major heart events in adults with diabetes and heart disease, and to lower kidney decline and cardiovascular death in adults with diabetes and chronic kidney disease [2]. Wegovy is the brand for weight reduction (adults, and teens 12 and older for the injection), for lowering heart attack, stroke and cardiovascular death in adults with heart disease and excess weight, and for MASH with moderate to advanced liver fibrosis [1].
Using Ozempic only for weight loss is outside its label [2]. So "is semaglutide the same as Ozempic?" has a two-part answer: Ozempic is semaglutide, but semaglutide is also sold as Wegovy (pen and pill) and in other forms.
Side-by-side
| Ozempic | Wegovy | |
|---|---|---|
| Approved for | Type 2 diabetes; heart and kidney outcomes in type 2 diabetes [2] | Weight reduction; heart-risk reduction with CVD; MASH (injection) [1] |
| Forms | Weekly pen [2] | Weekly pen; daily tablet [1] |
| Start | 0.25 mg weekly for 4 weeks, then 0.5 mg [2] | 0.25 mg weekly for 4 weeks, then 0.5, 1, 1.7 mg in 4-week steps [1] |
| Maintenance and max | 0.5, 1 or 2 mg; max 2 mg [2] | 1.7 or 2.4 mg; up to 7.2 mg for adult weight reduction [1] |
| Missed dose | Take within 5 days, otherwise skip [2] | Take if the next dose is more than 48 hours away, otherwise skip [1] |
| Nausea in trials | 15.8% at 0.5 mg, 20.3% at 1 mg vs 6.1% placebo [2] | 44% at 2.4 mg vs 16% placebo [1] |
| Self-pay (NovoCare) | $349 (0.25 to 1 mg), $499 (2 mg); $199 for first 2 low-dose fills [3] | $349 (0.25 to 2.4 mg); $199 for first 2 low-dose fills; 7.2 mg $399 [4] |
| List price | $1,028 a month [5] | $1,349 a month [5] |
| List price from Jan 1, 2027 | $675 a month [6] | $675 a month (2.4 mg pen, 25 mg tablet) [6] |
| Medicare GLP-1 Bridge | Not covered [7] | Covered, $50 copay if eligible [7] [8] |
Which is better for weight loss?
Wegovy is the one tested and approved for weight. In STEP 1, adults on Wegovy 2.4 mg lost an average of 14.9% of body weight at 68 weeks versus 2.4% on placebo, and half lost at least 15% [9]. Wegovy reaches higher doses than Ozempic's 2 mg maximum [1] [2]. We did not find Ozempic weight results in the label facts we reviewed for this page. See Wegovy results and Ozempic results.
Cost and insurance
At self-pay, the two cost the same at most doses: $349 a month through NovoCare, with a $199 price for new patients' first two fills at 0.25 or 0.5 mg through Dec 31, 2026 [3] [4]. With commercial coverage, either can drop to $25 a month, with savings capped at $100 a month [3] [4].
Coverage follows the label. Medicare's GLP-1 Bridge covers Wegovy for weight at a $50 copay but excludes Ozempic and people with type 2 diabetes [7] [8]. Details on Ozempic insurance, Wegovy insurance and Ozempic cost.
Compounded semaglutide is a third, different thing
Compounded semaglutide is not Ozempic or Wegovy. It is made by a compounding pharmacy, is not FDA-approved, and FDA does not review it for safety, effectiveness or quality [10]. FDA has warned companies that describing compounded semaglutide with the "same active ingredient as Ozempic and Wegovy" is misleading [11] [12]. FDA also says salt forms such as semaglutide sodium are different active ingredients with no lawful basis for compounding [10]. Read compounded semaglutide.
Taking both, switching, and stopping
Do not take Ozempic and Wegovy together. The Wegovy label says it is not recommended with other semaglutide-containing products or any other GLP-1 receptor agonist [1]. Neither label gives a direct Ozempic-to-Wegovy conversion; the labels share a 0.25 mg starting dose [2] [1], and your prescriber decides where you start. Label schedules: Ozempic dosage. See switching GLP-1s.
What happens when you stop: in the STEP 1 extension, people regained about two-thirds of the weight they had lost within a year of stopping semaglutide, and heart and blood sugar gains largely faded [13]. Plan the next step with your prescriber. More on stopping Wegovy and stopping Ozempic.
We may earn a commission if you sign up through some links on this page. It never changes a verdict. How we make money
Brand semaglutide online (clean, provisional)
- Clean
- Price
- Zepbound KwikPen $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg) a month; Wegovy pill $149 to $299; Wegovy pen $199 for the first 2 months at 0.25 to 0.5 mg, then $349, or $399 for 7.2 mg. Membership $39 the first month, then $74 to $149 a month. Checked Oct 17, 2026 [14].
- What you get
- FDA-approved brand drugs only (Zepbound, Wegovy pen and pill, Foundayo, Ozempic). Helps with insurance prior authorizations.
- FDA record
- No FDA warning letter found as of Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Membership is billed on top of the drug. The $74 rate needs a 12-month prepay. Verdict: clean (provisional). Ro review
- Clean
- Price
- Wegovy pill from $149, Wegovy pen from $199, Zepbound vial from $299 a month, plus a program fee of $39 the first month and $149 a month after. Checked Oct 17, 2026 [15].
- What you get
- Brand GLP-1s with insurance help. Says compounded drugs "may" be prescribed through a compounding partner, with no products or prices shown.
- FDA record
- No FDA warning letter found as of Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Its own pages list two different program fees ($149 and $75). Medicare patients are not eligible for the program. Verdict: clean (provisional). LifeMD review
- Price
- Membership $19.99 a month (first month free) plus $129 for the first visit without insurance; medication and labs extra. Checked Oct 17, 2026 [16].
- What you get
- Brand weight-loss prescriptions sent to your own pharmacy; no compounded drugs.
- FDA record
- No FDA warning letter found as of Oct 17, 2026.
- BBB
- BBB profile not checked as of Oct 17, 2026.
- Note
- Cheap visits, but you still pay the drug price at your pharmacy or through LillyDirect or NovoCare. Verdict: clean (provisional). PlushCare review
Warnings both labels share
Boxed warning for thyroid C-cell tumors in rodents; not for people with a personal or family history of medullary thyroid carcinoma or MEN 2 [1]. Seek care for severe stomach pain that does not go away (possible pancreatitis) or an allergic reaction. Low blood sugar is more likely with insulin or a sulfonylurea [1]. Both labels say to stop at least 2 months before a planned pregnancy [1] [2]. Call 911 in an emergency.
Questions people ask
Is Wegovy the same as Ozempic?
Is semaglutide the same as Ozempic?
Is Wegovy better than Ozempic for weight loss?
Can you take Ozempic and Wegovy at the same time?
No. The Wegovy label says it is not recommended with other semaglutide-containing products or any other GLP-1 receptor agonist [1].
Which costs more, Ozempic or Wegovy?
Is compounded semaglutide the same thing as Wegovy?
What happens when you stop Ozempic or Wegovy?
In the STEP 1 extension, people regained about two-thirds of their lost weight in the year after stopping semaglutide 2.4 mg, ending 5.6% below their starting weight on average [13].
Sources
16 cited
- Wegovy (semaglutide) injection and tablets prescribing information. DailyMed, NLM/NIH, Jun 2026.
- Ozempic (semaglutide) prescribing information. DailyMed, NLM/NIH, May 2026.
- Ozempic pricing and savings. Novo Nordisk (NovoCare), Oct 17, 2026.
- Wegovy self-pay offer. Novo Nordisk (NovoCare), Oct 17, 2026.
- TrumpRx.gov GLP-1 listings. TrumpRx.gov (US government), Oct 17, 2026.
- Novo Nordisk announces US list price reduction for Wegovy, Ozempic and Rybelsus. Novo Nordisk via PR Newswire, Feb 24, 2026.
- Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, Oct 17, 2026.
- Weight loss drugs coverage. Medicare.gov (CMS), Oct 17, 2026.
- Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine (PubMed), Feb 10, 2021.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. US Food and Drug Administration, Oct 1, 2026.
- Warning letter: Hims & Hers Health, Inc. dba Hims. US Food and Drug Administration, Sep 9, 2025.
- For telehealth companies: what to know when promoting compounded drugs. US Food and Drug Administration, Jun 15, 2026.
- Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension). Diabetes, Obesity and Metabolism (PubMed), May 19, 2022.
- Ro weight loss pricing. Ro, Oct 17, 2026.
- LifeMD weight management. LifeMD, Inc., Oct 17, 2026.
- PlushCare weight loss. PlushCare, Oct 17, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.